As we mark #MitochondrialDiseaseAwarenessWeek2026 (14-20 September), I would like to recognise the extraordinary global community of patients, families, clinicians, researchers, healthcare professiona...

Here is our fresh selection of papers on #Mitochondria in #Health & #Disease published last week! https://lnkd.in/e_VnGv7y #MitochondrialDisease 📚 Among highlights ➡️ Leucine-rich repeat kinase 2 im...

Florian Rosenberger receives a ERC Starting Grant, and adds his name to the growing list of SciLifeLab Fellows receiving prestigious grants.

This review analyzes strategies to prevent or reduce the transmission of diseases caused by pathogenic variants in mitochondrial DNA (mtDNA). Among these, we will focus on prenatal screening,…

TRiMAD 2026, Early registration ends September 14 for an unusually accessible two-day gathering of leading mitochondrial researchers. There are not many opportunities to spend two days in one place wi...

In the quest for longevity and improved health, scientists are exploring unconventional avenues that mimic the physiological benefits of high-altitude living. Researchers from the Gladstone Institutes have made a groundbreaking advancement by developing a drug that replicates the cellular advantages of low-oxygen therapy, specifically targeting inherited mitochondrial diseases. This innovative approach could change the lives of many, particularly those battling deadly conditions like Leigh Syndrome.

UCB’s developmental treatment may be eligible for patient access